COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated

被引:8
作者
Mboussou, Franck [1 ]
Farham, Bridget [1 ]
Nsasiirwe, Sheillah [1 ]
Atagbaza, Ajiri [1 ]
Oyaole, Daniel [1 ]
Atuhebwe, Phionah Lynn [1 ]
Alegana, Victor [1 ]
Osei-sarpong, Fred [1 ]
Bwaka, Ado [1 ]
Paluku, Gilson [1 ]
Petu, Amos [1 ]
Efe-Aluta, Oniovo [1 ]
Kalu, Akpaka [1 ]
Bagayoko, Magaran Monzon [1 ]
Impouma, Benido [1 ]
机构
[1] WHO, Reg Off Africa, POB 06, Brazzaville, Rep Congo
关键词
African region; COVID-19; vaccines; coverage;
D O I
10.3390/vaccines11051010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study summarizes progress made in rolling out COVID-19 vaccinations in the African region in 2022, and analyzes factors associated with vaccination coverage. Data on vaccine uptake reported to the World Health Organization (WHO) Regional Office for Africa by Member States between January 2021 and December 2022, as well as publicly available health and socio-economic data, were used. A negative binomial regression was performed to analyze factors associated with vaccination coverage in 2022. As of the end of 2022, 308.1 million people had completed the primary vaccination series, representing 26.4% of the region's population, compared to 6.3% at the end of 2021. The percentage of health workers with complete primary series was 40.9%. Having carried out at least one high volume mass vaccination campaign in 2022 was associated with high vaccination coverage (beta = 0.91, p < 0.0001), while higher WHO funding spent per person vaccinated in 2022 was correlated with lower vaccination coverage (beta = 0.26, p < 0.03). All countries should expand efforts to integrate COVID-19 vaccinations into routine immunization and primary health care, and increase investment in vaccine demand generation during the transition period that follows the acute phase of the pandemic.
引用
收藏
页数:14
相关论文
共 43 条
  • [1] COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods
    Al Hasan, Syed Mahfuz
    Saulam, Jennifer
    Mikami, Fumiaki
    Kanda, Kanae
    Yokoi, Hideto
    Hirao, Tomohiro
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (07) : 726 - 733
  • [2] Al-Kassim Hassan Mohammed, 2022, Ther Adv Vaccines Immunother, V10, p25151355221088159, DOI 10.1177/25151355221088159
  • [3] [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461
  • [4] [Anonymous], 2021, AM J MAN CAR TIM COV
  • [5] [Anonymous], 2005, INT HLTH REG
  • [6] An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes
    Antonini, Marcello
    Eid, Marwa Atef
    Falkenbach, Michelle
    Rosenbluth, Sharona Tsadok
    Prieto, Pablo Arija
    Brammli-Greenberg, Shuli
    McMeekin, Peter
    Paolucci, Francesco
    [J]. HEALTH POLICY AND TECHNOLOGY, 2022, 11 (02)
  • [7] Purposeful selection of variables in logistic regression
    Bursac, Zoran
    Gauss, C. Heath
    Williams, David Keith
    Hosmer, David W.
    [J]. SOURCE CODE FOR BIOLOGY AND MEDICINE, 2008, 3 (01):
  • [8] Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis
    Chisale, Master R. O.
    Ramazanu, Sheena
    Mwale, Saul Eric
    Kumwenda, Pizga
    Chipeta, Mep
    Kaminga, Atipatsa C.
    Nkhata, Obed
    Nyambalo, Billy
    Chavura, Elton
    Mbakaya, Balwani C.
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (02)
  • [9] ESRI ArcGIS, ARCGIS MAPP AN PLARF
  • [10] Resources or trust: What matters more in the vaccination strategies of high-income liberal democracies?
    Falkenbach, Michelle
    Willison, Charley
    [J]. HEALTH POLICY AND TECHNOLOGY, 2022, 11 (02)